While cigarette smoking and chronic alcohol consumption are the major risk
factors for the development of head and neck cancer, it is assumed that gen
etic factors contribute to risk. Glutathione-S-transferase GSTM1 AB, GSTM3
BE and GSTP1 AA as well as TNF genotypes were determined from leucocyte DNA
in 392 patients with head and neck carcinoma and 216 controls, with added
immunohistochemical studies. Comparative genomic hybridization was used to
screen for genetic alterations in the tumor tissue. Results: White the freq
uency of GSTM1 AB was significantly lower in all head and neck carcinomas c
ompared with controls, GSTM3 BE was significantly lower in the laryngeal an
d GSTP1 AA in the oral cavity/pharyngeal carcinoma cases; the frequency of
the TNFb3 allele was higher in the laryngeal cases. Chromosomal alterations
were specific for head and neck carcinomas, differing both in well differe
ntiated and undifferentiated and in metastasizing and non-metastasizing tum
ors. Conclusions: Allelism at GST gene loci mediates susceptibility to head
and neck carcinomas: GSTM1 AB is associated with a lower risk for all head
and neck carcinomas, GSTM3 BE only for laryngeal carcinomas and GSTP1 AA o
nly for oral cavity/pharyngeal carcinomas. The TNFb3 allele was significant
ly more frequent in laryngeal cancer patients. The genetic alterations in t
he tumor tissue are in line with the "tumor progression model". Genetic con
ditions are important from the first exposure with carcinogens up to late g
enetic events in the tumor tissue.